Iron Polymaltose Complex interactions
Checked as Iron (polysaccharide) in this data source.
Full monograph for Iron Polymaltose ComplexCheck it against another medicine
Medicines
98 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Alendronic acid | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Alendronic Acid + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The…2 documented mechanisms | 12 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethicone | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The…2 documented mechanisms | 12 sources — open the full entry |
| Aluminium Oxide + Magnesium Trisilicate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Baloxavir Marboxil | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed… | 1 sources — open the full entry |
| Beclomethasone Dipropionate + Chloramphenicol + Clotrimazole + Lidocaine | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Beta carotene + Vitamin C + Vitamin E | Moderate | Antagonism | Limited data suggest that vitamin E may diminish the therapeutic response to iron therapy in patients with iron deficiency anemia. | 2 sources — open the full entry |
| Calcium acetate + Magnesium carbonate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Carbonate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C + Vitamin D3 | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 + Multiminerals | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Carbidopa + LevodopaExtended releaseProlonged release | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Cefdinir | Moderate | Absorption | The oral bioavailability of cefdinir may be significantly decreased by concomitant administration of iron preparations. The proposed mechanism is chelation of… | 2 sources — open the full entry |
| Chloramphenicol (Oral) | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Chloramphenicol + Lidocaine Hydrochloride | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| CiprofloxacinbaseOphthalmic | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ciprofloxacin + Dexamethasone | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetate | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafine | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Deferiprone | Moderate | Antagonism | Deferiprone has the potential to bind polyvalent cations such as aluminum, iron and zinc, which may reduce its effectiveness. However, concurrent use with… | 1 sources — open the full entry |
| Delafloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Dexamethasone + Chloramphenicol | Moderate | Metabolism | Chloramphenicol can cause bone marrow depression and inhibit red blood cell maturation, which may interfere with the therapeutic effects of iron or vitamin B12… | 3 sources — open the full entry |
| Dexamethasone + Levofloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Dexlansoprazole | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Doxycycline Hydrochloride | Moderate | Absorption | The bioavailability of oral tetracyclines and iron salts may be significantly decreased during concurrent administration. Therapeutic failure may result. The… | 11 sources — open the full entry |
| Eltrombopag Olamine | Moderate | Absorption | Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly reduce the… | 2 sources — open the full entry |
| EsomeprazolebaseMUPS preparation | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Esomeprazole + Amoxicillin + Clarithromycin | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Ferric Carboxymaltose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Ferric Derisomaltose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Ferric Pyrophosphate Citrate | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Gatifloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Gemifloxacin | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Ibandronic Acid | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Ibandronic Acid + Algae Calcium + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Ibandronic Acid + Coral Calcium + Vitamin D3 | Moderate | Absorption | Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with… | 6 sources — open the full entry |
| Iron Sucrose | Moderate | Absorption | Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations. | 5 sources — open the full entry |
| Lansoprazole | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Lansoprazole + Amoxicillin + Clarithromycin | Moderate | Absorption | Inhibitors of the proton pump (PPIs or potassium-competitive acid blockers [PCABs]) may impair the gastrointestinal absorption of nonheme iron, a process that… | 12 sources — open the full entry |
| Lanthanum Carbonate | Moderate | Absorption | Theoretically, lanthanum carbonate may chelate with certain drugs in the gastrointestinal tract, resulting in reduced oral bioavailability of those drugs… | 6 sources — open the full entry |
| Levodopa + Benserazide | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Levodopa + Carbidopa | Moderate | Absorption | The oral bioavailability and pharmacologic effects of levodopa and carbidopa may be decreased during concurrent administration with iron-containing products… | 4 sources — open the full entry |
| Levodopa + Carbidopa + Entacapone | Moderate | Absorption | The oral bioavailability of entacapone and iron salts may be decreased during concurrent administration. The proposed mechanism is chelation of iron by…2 documented mechanisms | 5 sources — open the full entry |
| Levofloxacin (Eye/Ear) | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Levofloxacin Hemihydrate | Moderate | Absorption | Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics. Absorption… | 32 sources — open the full entry |
| Levothyroxine Sodium | Moderate | Absorption | Concurrent administration of iron-containing products may decrease the oral bioavailability and pharmacologic effects of levothyroxine. The exact mechanism of… | 1 sources — open the full entry |
This source documents no food, condition or duplication entries for Iron Polymaltose Complex.